Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Christine Lebrun Frenay is active.

Publication


Featured researches published by Christine Lebrun Frenay.


Neuroimmunology and Neuroinflammation | 2015

Early CNS neurodegeneration in radiologically isolated syndrome

Christina Azevedo; Eve Overton; Sankalpa Khadka; Jessica Buckley; Shuang Liu; Mehul P. Sampat; Christine Lebrun Frenay; Aksel Siva; Darin T. Okuda; Daniel Pelletier

Objective: Increasing evidence indicates that the thalamus may be a location of early neurodegeneration in multiple sclerosis (MS). Our objective was to identify the presence of gray matter volume loss and thinning in patients with radiologically isolated syndrome (RIS). Methods: Sixty-three participants were included in this case-control study. Twenty-one patients with RIS were age- and sex-matched to 42 healthy controls in a 1:2 ratio. All participants underwent brain MRIs on a single 3T scanner. After lesion segmentation and inpainting, 1 mm3-isometric T1-weighted images were submitted to FreeSurfer (v5.2). Normalized cortical and deep gray matter volumes were compared between patients with RIS and controls using t tests, and thalamic volumes were correlated with white matter lesion volumes using Pearson correlation. Exploratory cortical thickness maps were created. Results: Although traditional normalized total gray and white matter volumes were not statistically different between patients with RIS and controls, normalized left (0.0046 ± 0.0005 vs 0.0049 ± 0.0004, p = 0.006), right (0.0045 ± 0.0005 vs 0.0048 ± 0.0004, p = 0.008), and mean (0.0045 ± 0.0005 vs 0.0049 ± 0.0004, p = 0.004) thalamic volumes were significantly lower in patients with RIS (n = 21, mean age 41.9 ± 12.7 years) than in controls (n = 42, mean age 41.4 ± 11.2 years). Thalamic volumes correlated modestly with white matter lesion volumes (range: r = −0.35 to −0.47). Conclusion: Our data provide novel evidence of thalamic atrophy in RIS and are consistent with previous reports in early MS stages. Thalamic volume loss is present early in CNS demyelinating disease and should be further investigated as a metric associated with neurodegeneration.


Neurology | 2015

Effect of MD1003 (High Doses of Biotin) in Progressive Multiple Sclerosis: Results of a Pivotal Phase III Randomized Double Blind Placebo Controlled Study (PL2.002)

Ayman Tourbah; Christine Lebrun Frenay; Gilles Edan; Michel Clanet; Caroline Papeix; Sandra Vukusic; Jérôme De Seze; Marc Debouverie; Olivier Gout; Pierre Clavelou; Gilles Defer; David Laplaud; Thibault Moreau; Pierre Labauge; Bruno Brochet; Frédéric Sedel; Jean Pelletier


Neurology | 2013

ENIGM: A French Observational Study about Switching from Natalizumab to Fingolimod in Multiple Sclerosis (S41.002)

Mikael Cohen; Elisabeth Maillart; Caroline Papeix; Sandra Vukusic; David Brassat; Jérôme De Seze; Ayman Tourbah; Sandrine Wiertlewski; David Laplaud; Sylvie Courtois; Faycal Derouiche; Loic Chambaud; Clotilde Boulay; Bruno Brochet; Marc Debouverie; Olivier Casez; Olivier Heinzlef; J.-C. Ouallet; Bruno Stankoff; Giovanni Castelnovo; Emmanuelle Le Page; Gilles Defer; Nathalie Derache; Olivier Anne; Eric Berger; Lucien Rumbach; J.-P. Camdessanché; Audrey Kopf; Marie Fleury; Irina Malikova


Neurology | 2015

Multi-center, randomized, double-blinded assessment of dimethyl fumarate in extending the time to a first attack in radiologically isolated syndrome (RIS) (ARISE Trial) (P7.207)

Darin T. Okuda; Christine Lebrun Frenay; Aksel Siva; Christophe Hotermans; Christian von Hehn; Gina Remington; Braeden D. Newton; Teresa C. Frohman; Elliot M. Frohman; Orhun Kantarci; Daniel Pelletier


Neurology | 2017

Bevacizumab : is the lower the better for glioblastoma patients in progression? (P5.167)

Lila Sirven-Villaros; V. Bourg; Lydiane Mondot; Denys Fontaine; Fanny Vandenbos; Christine Lebrun Frenay


Neurology | 2017

Multi-center, randomized, double-blinded assessment of teriflunomide in extending the time to a first clinical event in radiologically isolated syndrome (RIS) The TERIS study (P6.359)

Christine Lebrun Frenay; Aksel Siva; Christina Azevedo; Maria Pia Sormani; Daniel Pelletier; Darin T. Okuda


Neurology | 2016

Pediatric Radiologically Isolated Syndrome: Clinical and Radiological Outcomes (S29.002)

Naila Makhani; Christine Lebrun Frenay; Aksel Siva; Clarisse Carra-Dalliere; Jérôme De Seze; Francoise Durand Dubief; Orhun Kantarci; Megan Langille; Jean Pelletier; Juan Ignacio Rojas; Teri Schreiner; Mar Tintoré; Ugur Uygunoglu; Darin T. Okuda; Daniel Pelletier


Neurology | 2016

Radiologically Isolated Syndrome: Pathologically Defined as Demyelinating Disease (P1.391)

Mark T. Keegan; Yong Guo; Darin T. Okuda; Aksel Siva; Daniel Pelletier; Orhun Kantarci; Claudia F. Lucchinetti; Christine Lebrun Frenay


Neurology | 2016

Therapeutic Target of Memory B Cells Depletion Helps to Tailor Administration Frequency of Rituximab in Neuromyelitis Optica Spectrum Disorders Patients (P5.310)

Christine Lebrun Frenay; Mikael Cohen; Gwendoline Romero; Alessandra Rosenthal-Allieri; Michel Ticchioni


Neurology | 2016

Therapeutic target of memory B cells depletion helps to tailor administration frequency of Rituximab in myasthenia gravis (P3.170)

Christine Lebrun Frenay; V. Bourg; Mikael Cohen; Alexandra Rosenthal; Claude Desnuelle; Michel Ticchioni

Collaboration


Dive into the Christine Lebrun Frenay's collaboration.

Top Co-Authors

Avatar

Daniel Pelletier

University of Southern California

View shared research outputs
Top Co-Authors

Avatar

Darin T. Okuda

University of Texas Southwestern Medical Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Mikael Cohen

University of Nice Sophia Antipolis

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge